openPR Logo
Press release

The Rising Demand for Hemostatic Agents in Minimally Invasive Procedures | Major Companies are Integralife Lifesciences, Artivion, Medesy.

06-20-2025 08:47 AM CET | Health & Medicine

Press release from: DataM Intelligence 4market Research LLP

Hemostats Market

Hemostats Market

Global Hemostats Market is expected to reach at a Significant CAGR during the forecast period 2024-2031

The Hemostats Market takes center stage in DataM Intelligence's latest comprehensive research, where industry experts deliver cutting-edge analysis powered by robust data analytics and strategic market intelligence. This groundbreaking study dives deep into the competitive ecosystem, spotlighting market leaders and their innovative approaches to product development, competitive pricing models, financial performance, and expansion strategies. The research unveils critical market forces, competitive positioning, and breakthrough trends that will define the industry's trajectory in the coming years, providing stakeholders with actionable intelligence to navigate this rapidly evolving marketplace.

Unlock exclusive insights with our detailed sample report (Please enter your Corporate Email ID to get priority access):- https://datamintelligence.com/download-sample/hemostats-market?rk

Hemostats are medical devices used to promote hemostasis (the stopping of bleeding) during surgical procedures or trauma care. They function by mechanically clamping blood vessels, using absorbable materials, or chemically accelerating the clotting process. Hemostats are essential in surgeries involving highly vascularized tissues and are commonly used in orthopedic, cardiovascular, general, and reconstructive surgeries. The market includes various products such as mechanical, active, flowable, and sealant-based hemostats. The rising volume of surgical procedures and innovations in biomaterials continue to drive market demand.

Latest Trends:

Growing adoption of minimally invasive surgeries driving demand for advanced hemostats

Integration of bioactive hemostats to improve patient outcomes

Increased use of combination hemostats for complex surgeries

Rising investment in R&D for next-gen, faster-acting products

Expansion of usage in outpatient and ambulatory settings

Hemostats Market: Industry Giants and Emerging Leaders:

Integralife Lifesciences, Artivion, Medesy, World Precision Instruments, Agnthos, GerMed USA, Burtons Veterinary, Prodent USA, Thermo Fisher Scientific Inc, Bausch & Lomb Incorporated.

Hemostats Industry News:

Major players are launching next-gen hemostatic agents with enhanced bioabsorption

Strategic collaborations between medical device companies and biotech firms to develop novel hemostatic technologies

Increasing FDA approvals for new formulations and innovative delivery systems

Asia-Pacific emerging as a high-growth region due to rising healthcare infrastructure investments

Ongoing clinical trials to validate safety and efficacy of bioactive and synthetic hemostats

Research Methodology

Our comprehensive research approach leverages a dual-methodology framework that seamlessly integrates qualitative insights with quantitative data analysis to deliver robust market intelligence. The process begins with extensive secondary research, where we meticulously collect information from authoritative industry publications, proprietary databases, and verified market sources. This foundation is strengthened through targeted primary research initiatives, including strategic surveys and in-depth interviews with industry veterans, market experts, and key stakeholders.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/hemostats-market

Segment Covered in the Hemostats Market:

By Product type: Halstead mosquito hemostatic forceps, Helly and Crile hemostatic forceps, Rochester-carmalt hemostatic forceps, Others

By Application: Cardiovascular surgery, General surgery, Gynecological surgery, Reconstructive surgery, Neurological surgery, Orthopedic surgery, Others

By End User: Hospitals, Ambulatory Surgical Centers, Others

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, Market Access, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Top-down and bottom-up approach for regional analysis

Regional Analysis for Hemostats Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)



Frequently asked questions:

➠ What is the global sales value, production value, consumption value, import and export of Hemostats market?

➠ Who are the global key manufacturers of the Hemostats Industry? How is their operating situation (capacity, production, sales, price, cost, gross, and revenue)?

➠ What are the Hemostats market opportunities and threats faced by the vendors in the global Hemostats Industry?

➠ Which application/end-user or product type may seek incremental growth prospects? What is the market share of each type and application?

➠ What focused approach and constraints are holding the Hemostats market?

➠ What are the different sales, marketing, and distribution channels in the global industry?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Looking For Detailed Full Report? Get it here: https://datamintelligence.com/buy-now-page?report=hemostats-market

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The Rising Demand for Hemostatic Agents in Minimally Invasive Procedures | Major Companies are Integralife Lifesciences, Artivion, Medesy. here

News-ID: 4075182 • Views:

More Releases from DataM Intelligence 4market Research LLP

United States Electric Vehicle Market Forecast 2025-2032: Impact of Next-Generation Batteries, Charging Infrastructure, and Automotive OEM Expansion on Market Dynamics | BMW Group, BYD Company Ltd., Daimler AG
United States Electric Vehicle Market Forecast 2025-2032: Impact of Next-Generat …
Global Electric Vehicle Market reached US$599.50 billion in 2024 and is expected to reach US$1,194.54 billion by 2032, growing with a CAGR of 9% during the forecast period 2025-2032. The global electric vehicle market encompasses battery-electric, plug-in hybrid, and fuel cell vehicles. EVs are adopted to reduce carbon emissions, improve fuel efficiency, and meet regulatory mandates. Growth is fueled by technological advances in batteries, charging infrastructure, and government incentives. Consumer preference
Global Lymphedema Market 2025-2033: Advancements in Compression Therapy, Minimally Invasive Procedures, and Wearable Devices Driving Market Growth | Tactile Medical, Bio Compression Systems, Inc., BSN-JOBST
Global Lymphedema Market 2025-2033: Advancements in Compression Therapy, Minimal …
The Global Lymphedema Market reached US$ 989.85 million in 2024 and is expected to reach US$ 2,029.90 million by 2033, growing at a CAGR of 8.8 % during the forecast period of 2025-2033. The global lymphedema market focuses on therapies and devices to manage this chronic condition caused by lymphatic fluid accumulation. Treatments include compression garments, physical therapy, and surgical interventions. Market growth is driven by rising prevalence, especially post-cancer surgeries.
Lab-Grown Diamonds Market Size, Share, Growth Analysis, and Forecast (2025-2032): Sustainable Alternatives Transforming Jewelry and Industrial Applications | Top Manufacturers are ABD Diamonds, WD Advanced Materials, LLC & Adamas One Corp.
Lab-Grown Diamonds Market Size, Share, Growth Analysis, and Forecast (2025-2032) …
As per DataM Intelligence Experts Research Report Global lab-grown diamonds market reached US$ 25.68 billion in 2024 and is expected to reach US$ 55.45 billion by 2032, growing with a CAGR of 10.10% during the forecast period 2025-2032. The lab-grown diamonds market involves diamonds produced using chemical vapor deposition (CVD) or high-pressure high-temperature (HPHT) methods. These diamonds are visually and chemically similar to mined diamonds but are more sustainable. Market growth
United States CRISPR Market Size, Share, Growth Analysis, and Forecast (2025-2033): Gene Editing Innovations Reshaping Therapeutics, Agriculture, and Biotechnology | Takara Bio Inc., QIAGEN, Eurofins Genomics.
United States CRISPR Market Size, Share, Growth Analysis, and Forecast (2025-203 …
CRISPR market reached US$ 3.93 billion in 2024 and is expected to reach US$ 15.92 billion by 2033, growing at a CAGR of 16.8% during the forecast period 2025-2033. The global CRISPR market focuses on the development and commercialization of gene-editing technologies for therapeutics, agriculture, and research. CRISPR enables precise modification of genetic sequences for disease treatment and crop improvement. Growth is fueled by rising biotechnology investments and research applications. Ethical

All 5 Releases


More Releases for Hemostats

Absorbable Hemostats Market Overview
In today's dynamic global economy, the absorbable hemostats market is emerging as a beacon of opportunity and innovation. With rapid technological advancements, evolving consumer demands, and proactive government policies shaping the landscape, this sector is setting the stage for transformative change. Our in-depth analysis delves into historical market trends, current dynamics, and future projections, providing industry leaders, investors, and decision-makers with the strategic insights needed to navigate this competitive terrain. 𝐆𝐞𝐭
Hemostats Market Insights, Forecast to 2031
A new Report by DataM Intelligence, titled "Hemostats Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2031,"" offers a comprehensive analysis of the industry, which comprises insights on the Hemostats market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the market. This report has a complete table of contents, figures, tables, and charts, as well as insightful analysis. The Hemostats market has been growing significantly
Hemostats Market Size, Outlook, Overview 2024-2033
The hemostats market size has grown strongly in recent years. It will grow from $3.17 billion in 2023 to $3.46 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to surgical advancements, rising geriatric population, chronic diseases and coagulation disorders, expansion of cardiovascular surgeries, orthopedic applications. The hemostats market size is expected to see strong growth in
Hemostats Market worth $3.7 billion by 2028
Hemostats Market in terms of revenue was estimated to be worth $2.7 Billion in 2023 and is poised to reach $3.7 Billion by 2028, growing at a CAGR of 6.7% from 2023 to 2028 according to a new report by MarketsandMarkets. The significant growth in the number of hospitals and surgical centers is expected to support the growth of the hemostats market, as these are key end users of hemostats. The
Global Hemostats and Tissue Sealants Market
Global Hemostats and Tissue Sealants Market –Industry Analysis and Forecast 2018-2026 – By Product Type, Application, End-user, and Region. Global Hemostats and Tissue Sealants Market was valued US$ 2.78 Bn in 2017 and is expected to reach US$ 5.29 Bn by 2026, at a CAGR of 8.37% during a forecast period. Increasing incidence of chronic diseases, the wide range of applications, patient safety & quick recovery, number of surgeries and growing aging
Hemostats Market worth $3.03 billion by 2023
According to the new market research “"Hemostats Market by Product (Thrombin, Oxidised Regenerated Cellulose, Combination, Gelatin, Collagen), Application (Gynecology, Neurology, Cardiovascular, Reconstructive), Formulation (Powder, Matrix & Gel, Sheets & Pads) - Global Forecast to 2023", The hemostats market is expected to reach USD 3.03 billion by 2023 from USD 2.27 billion in 2018, at a CAGR of 6.0%. Don’t miss out on business opportunities in Hemostats Market . Speak to our